Form 4 for TMO Thermo Fisher Scientific
Accepted 2023-02-24 00:00:00 ET · period of report 2023-02-22 · accession 0001127602-23-007102 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-24 | 2023-02-23 | TMO | Pettiti Gianluca | EVP | F - Tax | $550.95 | -1,171 | 19.6K | -6% | -$645.2K |
| DM | 2023-02-24 | 2023-02-22 | TMO | Pettiti Gianluca | EVP | A - Grant | $0.00 | +6,283 | 15.9K | +65% | $0 |
| D | 2023-02-24 | 2023-02-22 | TMO | Pettiti Gianluca | EVP | A - Grant | $0.00 | +9,702 | 9,702 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-23 | F | D | 449 | $550.95 | 20,284 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-22 | A | A | 4,818 | $0.00 | 20,733 | D | — | — | (F1) Shares represent a performance-based restricted stock unit award granted on February 23, 2022. The Company's Compensation Committee determined on February 22, 2023, that the performance criteria related to this award were satisfied. One-third of the shares vest on February 28, 2023 and 2024. The remaining one-third will vest on February 28, 2025, and is subject to adjustment (positive or negative) for long-term performance which is based on the comparison of the Company's total shareholder return compound annual growth rate ("CAGR") to the total shareholder return CAGR of each of the companies in the peer group, as specified within the award agreement, over the measurement period starting on January 1, 2022, through to December 31, 2024. |
| 3 | Common | Common Stock | 2023-02-22 | A | A | 1,465 | $0.00 | 15,915 | D | — | — | |
| 4 | Common | Common Stock | 2023-02-23 | F | D | 722 | $550.95 | 19,562 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2023-02-22 | A | A | 9,702 | $0.00 | 9,702 | D | $548.40 · — to 2031-02-22 | 9,702 Common Stock | (F2) The option vests in four equal annual installments beginning on February 28, 2024. |